Supporting Figures
Supporting Figure 1 . Fluorescence polarization assays of various 14-3-3 binding-partners. 14-3-3σ is titrated to FITC-labeled 14-3-3 binding peptides (10 nM, indicated by the vertical dashed line) at various concentrations of FC-A between 0 and 500 µM. Experiments are performed as triplicates and errors bars indicate the standard deviations. The cooperativity factor α, defined as the ratio between stabilized affinity and the non-stabilized affinity of the peptide for the receptor, KD
I / KD
III is obtained though data-fitting according to the model depicted in Supporting Figure 5 . The intrinsic affinity of FC-A is determined to be around 300 µM. 
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Experimental Procedures
General information
Fusicoccin A and J were obtained as a metabolite of Phomopsis amygdali. FC-A aglycone and FC-J aglycone   2,4  ,   FC-THF and DP FC-THF   2 , and FC-NAc 5 were made according to the corresponding literature procedures. Unless otherwise noted, all other reagents were obtained from commercial suppliers and used without further purification. All the NMR data were recorded on either a Varian Gemini 400 MHz NMR, a Bruker Cryomagnet 400 MHz, or a Bruker UltraShield Magnet 400 MHz, (400 for 1H NMR and 100 13C NMR). Proton experiments are reported in parts per million, ppm) downfield of the signal for tetramethylsilane (TMS). All 13 C spectra are reported in ppm relative to the signal for residual chloroform (77 ppm) or methanol (49 ppm). Analytical LC-MS was performed on a C4, Jupiter SuC4300A, 150 × 2.00 mm column with a gradient 5%−100% acetonitrile in H2O supplemented with 0.1% v/v formic acid (FA) in 15 min. Silica column chromatography was performed manually using silica with particle size 60−200 μm. The purity and exact mass of the compounds were determined using a High Resolution LC-MS system consisting of a Waters ACQUITY UPLC I-Class system coupled to a Xevo G2 quadrupole time of flight (Q-tof) system. The system comprised a Binary Solvent Manager and a Sample Manager with Fixed-Loop (SM-FL). compounds were separated (0.3 mL min−1 ) on the column (Polaris C18A reverse phase column 2.0 × 100 mm, Agilent) using a 15%−75% acetonitrile gradient in water supplemented with 0.1% v/v FA before analysis in positive mode in the mass spectrometer. On the basis of LC-UV data, all synthesized FC analogs were prepared to ≥95% purity.
Protein expression
His6-tagged 14-3-3σ protein full-length was expressed in NiCo21(DE3) competent cells with a pPROEX HTb plasmid (0.4 mM IPTG, overnight at 18°C), and purified using Ni 2+ -affinity chromatography. The proteins were dialyzed against FP-buffer (10 mM HEPES pH 7.4, 150mM NaCl) before usage.
Peptide synthesis
Peptides were synthesized via Fmoc solid-phase peptide synthesis (SPPS) using an automated Intavis MultiPep RSi peptide synthesizer. TentaGel R RAM resin (Rapp Polymere; 0.18 mmol/g loading) was used for the synthesis of all peptides. Fmoc-protected amino acid building blocks (Novabiochem®) were dissolved in N-methylpyrrolidone (NMP) and coupled sequentially by double coupling to the resin using N,N-diisopropylethylamine(DIPEA)/(2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophos-phate) (HBTU) (4:1 v/v). Fmoc-deprotection was achieved using 20% piperidine in NMP. The peptides were labeled with FITC (Sigma-Aldrich) attached via a short polyethylene glycol-based linker introduced via Fmoc-O1Pen-OH (Iris Biotech) or hexanoic acid-based linker via Fmoc-Ahx-OH (Iris Biotech) following reported procedures. 6 Resin cleavage of the protected peptide was performed using 2.5%/2.5%/95% H2O/triisopropylsilane (TIS)/trifluoroacetic acid (TFA) and the peptides were subsequently precipitated in ice-cold diethylether. The resultant crude solid was then re-dissolved in acetonitrile/water/0.1%TFA and lyophilized.
The peptides were further purified using a preparative reversed-phase high performance liquid chromatography (HPLC) system which comprised of a LCQ Deca XP Max (Thermo Finnigan) ion-trap mass spectrometer equipped with a Surveyor autosampler and Surveyor photodiode detector array (PDA) detector (Thermo Finnigan). Solvents were pumped using a high-pressure gradient system using two LC-8A pumps (Shimadzu) for the preparative system and a two LC-20AD pumps (Shimadzu) for the analytical system. The crude mixture was purified on a reversephase C18 column (Atlantis T3 prep OBD, 5 µm, 150 x 19 mm, Waters) using a flow of 20 mL/min and linear acetonitrile gradient in water with 0.1% v/v trifluoracetic acid (TFA). Fractions with the correct mass were collected using a PrepFC fraction collector (Gilson Inc).
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The purity was established by analytical reversed-phase HPLC-MS using a Shimadzu HPLC on a Atlantis® T3 C18 analytical column (2.1x150 mm) LCQ Fleet from Thermo Scientific, Surveyor AS and PDA with an eluent flow rate of 0.2 mL/min (MeCN/H2O/0.1%TFA) 0-1 min, isocratic, 5% acetonitrile (MeCN); 1-10 min, linear gradient, 5-70%; 10-11 min, isocratic, 70%; 11-12 min, linear gradient, 70-5%; 12-15 min, isocratic, 5% MeCN. The mass off all peptides corresponded with the calculated mass, with a purity >90%, as determined via the UVtrace.
The p53-peptide (TAMRA-Ahx-SRAHSSHLKSKKGQSTSRHKKLMFK(pT)EGPDSD-COOH) was obtained via Anaspec.
7 (Ahx = 6-amino-hexanoic acid)
Fluorescence polarization measurements
Fluorescence anisotropy affinity measurements were conducted in FP-buffer (10 mM HEPES pH 7.4, 150 mM NaCl) with 0.01% TWEEN-20 and 1.0 mg/mL BSA, using fixed concentrations of fluorescently-labeled peptide (10 nM) and DMSO (2% v/v) in 10 µL round-bottom low binding 384-micro well plates (Corning, #25916024 
Synthesis of FC-A 3'-deAc
To a solution of FC-A (180 mg, 0.27 mmol) in MeOH (25.0 mL) was added sat. NaHCO3 (30 mL). After stirring at room temperature (rt) for 30 min, the solution was diluted with EtOAc and poured into sat. KHSO4. The organic layer was separated, and the aqueous layer extracted with EtOAc. The combined organic layers were washed with brine and dried over sodium sulfate. After filtration, the solvent was removed in vacuo. The residue was purified by flash column chromatography on silica gel to yield FC-A 3′-deAc as a colorless solid (150 mg, 0.24 mmol, 89% 
Synthesis of FC-A (19,3')dideAc
To a solution of FC-A (100 mg, 0.15 mmol) in 1.36 mL MeOH was 43.3mg. K2CO3. After stirring at room temperature (rt) for 30 min, the solution was acidified 10% citric acid and extracted with chloroform. The combined organic layers were washed with brine and dried over sodium sulfate. After filtration, the solvent was removed in vacuo. The residue was purified by flash column chromatography on silica gel to yield FC-A (19,3′)-dideAc as a colorless solid, 96 mg (0.142 mmol, 95% 
Synthesis of FC-J DP
FC-J (440 mg, 0.666 mmol) was dissolved in 10 mL methanol and heated to 60 °C. To the solution was added 3.5 mL 2.0 M HCl aqueous solution and the reaction stirred for 6 h. After cooling down, the reaction was quenched with 1 mL NEt3, the solvent evaporated and the crude product purified by silica gel chromatography (DCM/acetone/MeOH 100/50/17 v/v/v) yielding a colorless oil. The oil was dissolved in MilliQ water and lyophilized yielding 263 mg (0.51 mmol, 77%) of FC-J DP as a white amorphous powder. LC-MS: [ 
Synthesis of FC-J Acetonide
FC-J DP (163 mg, 0.318 mmol) was dried by azeotropical distillation from 2 x 20 mL toluene/EtOH 8/1 v/v and 1 x 20 mL toluene. The dried flask was back-filled with argon and the material dissolved in 10 mL anhydrous acetone (overnight drying in CaSO4). To the solution were added 125 µL 2,2-dimethoxypropane and 5 mg pyridinium paratoluenesulfonate (PPTS) and the temperature was raised to 40 °C. After stirring overnight, an additional 50 µL 2,2-dimethoxypropane was added and again after an additional 6 h. After stirring for 1 h after the last addition, the reaction mixture was diluted in Et2O and poured into brine. The mixture was extracted with Et2O thrice, dried over MgSO4, filtered and the solvent evaporated. 
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Mathematical Model Derivation and numerical solution
Supporting Figure 4 depicts the scheme of equilibria involved in protein-protein interaction stabilization via sequential addition of model peptide and stabilizer to a receptor protein via pathway A or pathway B, stabilizer and peptide respectively. The peptide-ligand binds to a receptor with KD I , in the presence of a stabilizer, this affinity is altered to KD III . Similarly, the stabilizer binds with an intrinsic affinity KD II and an enhanced affinity KD IV when the peptide is already bound.
Definition of terms:
Rtot : total concentration of 14-3-3 monomer Ptot:
total concentration of labeled partner Stot:
total concentration of stabilizer compound 
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The mass-balances of the total concentration of receptor protein, stabilizer and labeled partner species are first partitioned between their respective free forms and various complexes (Eq. 1-3).
Next, the equilibrium equations of the dissociation constant KDs, and its related species are expressed. (Eq. 4-7).
The cooperativity constant α is defined as the ratio of non-stabilized and stabilized binding:
The equilibrium constants are substituted in Eq. 6 & 7:
The equilibrium equations are then rewritten to obtain expressions for all complexes [R⦁P], [R⦁S], [R⦁S⦁P] as a function of the dissociation constants relevant parameters and free concentrations of all species (Eq. 11-13).
The equations 11-13 are substituted in the mass-balance equations (Eq. 1-3) to arrive at the following expressions: 
Finally, custom-written MATLAB scripts are used to solve the coupled non-linear equations 17-19 for the free concentrations R, P and S through iteration over the three equations. The free concentrations R, P, and S can subsequently be filled in (Eq. 11-13) to calculate the equilibrium concentrations of all other species, most importantly the labeled species P, R⦁P and R⦁S⦁P. Once all the concentrations are calculated, the normalized calculated anisotropy signal (rmodel) is obtained by (Eq. 20):
Data analysis and parameter estimation
To determine KD II and α, we performed non-linear least square analysis on the 2D fluorescence anisotropy assay data as reported in Figures 1, 2, 3 in the main manuscript and Supporting Figure 1 . The experimental anisotropy data of all relative concentrations of receptor and stabilizer was compared to the anisotropy values of the modeled titration data.
Nonlinear least square minimization of the data was performed to minimize the cost function (Eq. 21) using the MATLAB function lsqnonlin, a subspace trust region method based on the interior-reflective Newton method. In order to prevent entrapment in a local minimum, 30 different starting values of KD II , α were defined, and the best fit (defined as the fit with the lowest square of the norm of the residuals) is taken as the final solution for the optimized values. The different initial parameter sets are defined using a latin hypercube sampling method (MATLAB function lhsdesign) 10 .
The MATLAB scripts can be obtain from the authors upon request. 
